In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

Vor Biopharma Inc. (VOR). Financial results for the first quarter of 2021.

07.05.2021

GAAP net loss - $0.63, which is $0.03 less than the same period last year.
Cash and cash equivalents - $262.6 million.